APO-ESLICARBAZEPINE DIN 02537966
Health Canada record
| Active ingredient(s) | ESLICARBAZEPINE ACETATE 600 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N03AF04 ESLICARBAZEPINE |
| Original market date | 06-May-2025 |
| Current status date | 06-May-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ESLICARBAZEPINE ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02537931 | APO-ESLICARBAZEPINE | APOTEX INC | Tablet | ESLICARBAZEPINE ACETATE 200 MG | Marketed |
| 02537974 | APO-ESLICARBAZEPINE | APOTEX INC | Tablet | ESLICARBAZEPINE ACETATE 800 MG | Marketed |
| 02537958 | APO-ESLICARBAZEPINE | APOTEX INC | Tablet | ESLICARBAZEPINE ACETATE 400 MG | Marketed |
| 02527448 | AURO-ESLICARBAZEPINE | AURO PHARMA INC | Tablet | ESLICARBAZEPINE ACETATE 400 MG | Marketed |
| 02527421 | AURO-ESLICARBAZEPINE | AURO PHARMA INC | Tablet | ESLICARBAZEPINE ACETATE 200 MG | Marketed |
| 02527456 | AURO-ESLICARBAZEPINE | AURO PHARMA INC | Tablet | ESLICARBAZEPINE ACETATE 600 MG | Marketed |
| 02527464 | AURO-ESLICARBAZEPINE | AURO PHARMA INC | Tablet | ESLICARBAZEPINE ACETATE 800 MG | Marketed |
| 02426870 | APTIOM | SUMITOMO PHARMA CANADA, INC. | Tablet | ESLICARBAZEPINE ACETATE 400 MG | Cancelled Post Market |
| 02426897 | APTIOM | SUMITOMO PHARMA CANADA, INC. | Tablet | ESLICARBAZEPINE ACETATE 800 MG | Cancelled Post Market |
| 02426862 | APTIOM | SUMITOMO PHARMA CANADA, INC. | Tablet | ESLICARBAZEPINE ACETATE 200 MG | Cancelled Post Market |
| 02426889 | APTIOM | SUMITOMO PHARMA CANADA, INC. | Tablet | ESLICARBAZEPINE ACETATE 600 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 34833 | 2025-02-13 | Abbreviated New Drug Submission (ANDS) |
International API supply for ESLICARBAZEPINE ACETATE
17 active FDA Drug Master Files.
Request a quote for APO-ESLICARBAZEPINE